The goal of this work was to develop a comprehensive understanding of the NB kinetics, and correlate the observed delays in PSMA-NB clearance from the tumors to receptor-mediated uptake of targeted NBs into the PSMA biomarker expressing tumor cells. The gene discussed is FOLH1; the disease is neoplasm.